Corrigendum to “Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib” [Leukemia Res. 79 (2019) 38–44]
Title:
Corrigendum to “Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib” [Leukemia Res. 79 (2019) 38–44]
Author:
Gerds, Aaron T. Tauchi, Tetsuzo Ritchie, Ellen Deininger, Michael Jamieson, Catriona Mesa, Ruben Heaney, Mark Komatsu, Norio Minami, Hironobu Su, Yun Shaik, Naveed Zhang, Xiaoxi DiRienzo, Christine Zeremski, Mirjana Chan, Geoffrey Talpaz, Moshe